ResMed Stock PerformanceShares of RMD stock traded down $11.39 during trading hours on Friday, reaching $211.84. Robert W. Baird set a $213.00 price target on ResMed in a report on Friday. ResMed Posts Strong Q4 Earnings and Lifts DividendThe company raised its quarterly dividend from $0.60 to , a 10% increase. Also, CEO Michael J. Farrell sold 4,991 shares of ResMed stock in a transaction on Tuesday, July 7th. ResMed Company Profile(Get Free Report)ResMed (NYSE: RMD) is a global medical device and cloud-connectivity company focused on improving outcomes for people with sleep-disordered breathing and chronic respiratory conditions.